Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35
🏠 Home   ➤    Stock news

Lumibird Establishes Presence in Southeast Asia by Acquiring Its Malaysian Distributor

Lumibird, the European leader in laser technologies, has announced the acquisition of its long-standing distribution partner BIZ MEDIC SDN BHD, based in Kuala Lumpur, Malaysia. This move marks the creation of Lumibird Medical Southeast Asia, a new hub aimed at centralizing the group's activities in the region.


Lumibird Establishes Presence in Southeast Asia by Acquiring Its Malaysian Distributor

Strategic Acquisition and Regional Focus

Lumibird Medical has finalized an agreement to acquire BIZ MEDIC SDN BHD, its distribution partner since 2004. This acquisition signifies a shift from a distribution model to a direct subsidiary approach, embedding the group in a strategy of strengthened presence in the Asia Pacific region. The establishment of Lumibird Medical Southeast Asia will position this area as the main growth driver for the group in a high-potential ophthalmological market. Southeast Asia is characterized by a strong clinical demand, notably high rates of visual disorders such as myopia, glaucoma, and retinal diseases, as well as a rapid increase in health infrastructure investments.

Operational Restructuring and Brand Presence

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The creation of the new hub will be accompanied by the simultaneous closure of the commercial office in Thailand and the subsidiary in India, thereby streamlining the group's regional operations. The new entity will organize the distribution of products from Quantel Medical, Optotek Medical, and Ellex, ensuring a unified brand presence tailored to the regulatory and clinical requirements of Southeast Asia. The completion of the operation is expected in the coming months, subject to obtaining certain local regulatory approvals. Lumibird Medical will continue to explore the potential sale of its medical division, the outcome of which remains uncertain.



Sector Santé · Défense · Technologie · Equipements médicaux Équipements Médicaux


Assurance vie

Context

Period
  • Period: 2025
Guidance from the release
  • L’année 2025 marque le retour à une belle dynamique de croissance de la division Photonique, réalisée sans compromis sur la marge.
  • Croissance soutenue des divisions Photonique et Médical, avec perspectives positives pour 2026 et amélioration des marges.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit